@mitrifit's peptide therapy claims need context

What did @mitrifit actually say?

The creator recommended Modern Aminos as a peptide supplier, offered a 10% discount code, and listed available compounds including TB-500, BPC-157, semaglutide analogs, KPV, MK-677, and injectable amino products. They also flagged something "fishy" with recent orders and asked buyers to DM order numbers. This is, at its core, an affiliate promotion for an unregulated peptide vendor.

The creator name-drops compounds like "GOP 3RT," "GOP 2TZ," and "1SM" which appear to be vendor-specific internal naming conventions for GLP-1 receptor agonist analogs, likely tirzepatide and semaglutide derivatives. They also mention "Tesla" which is a vendor SKU, not a standard compound name. Most viewers will not know what they are actually ordering.

Does the science back this up?

Some of the compounds mentioned have legitimate research behind them. The problem is not the molecules. The problem is the source and the framing. Research-grade peptides sold by gray-market vendors are not the same as clinically produced, quality-controlled compounds, and calling any of these suppliers "credible" without regulatory standing is a stretch.

BPC-157 has shown tissue repair activity in rodent models (Sikiric et al., 2018, Current Pharmaceutical Design), and TB-500 (Thymosin Beta-4) has wound-healing research behind it (Sosne et al., 2010, Cornea). KPV has demonstrated anti-inflammatory properties in preclinical work (Catania et al., 2004, Peptides). But none of these are FDA-approved for human use in the forms being sold here. MK-677, an oral ghrelin mimetic, has been studied for GH secretion (Nass et al., 2008, Journal of Clinical Endocrinology and Metabolism), but it is also on the FDA's list of compounds withdrawn from the compounding market.

What did they get wrong (or right)?

The creator got one thing right: pointing out that some payment processors require ID verification is accurate. Vendors in this space do use different processors for compliance reasons, and that nuance is real.

Everything else is a problem. Calling an unregistered peptide vendor a "credible source" is misleading. Credibility in a medical context means regulatory oversight, third-party testing, good manufacturing practice certification, and prescriber involvement. Modern Aminos has none of those in a verifiable public form. The creator also lists what appear to be tirzepatide and semaglutide analogs under obfuscated names like "GOP 3RT" and "GOP 2TZ." Selling GLP-1 analogs without a prescription is illegal in the United States. Framing that sale as routine and accessible to anyone with a discount code is not just misleading. It is potentially dangerous. Dosing errors with semaglutide analogs cause serious adverse events including pancreatitis and severe GI distress (FDA Drug Safety Communication, 2023).

What should you actually know?

If you are considering any of the compounds mentioned here, the vendor relationship matters as much as the molecule. Peptides purchased from gray-market sources have no guaranteed purity, concentration accuracy, or sterility. A 2022 analysis published in JAMA found that compounded semaglutide products varied significantly from labeled concentrations, raising real safety flags.

A legitimate telehealth path exists for many of these compounds. BPC-157, KPV, and some growth hormone secretagogues can be prescribed and dispensed through FDA-registered 503A or 503B compounding pharmacies with a licensed provider overseeing dosing and indication. That is not what this video describes. What this video describes is a discount code and a DM request, which should tell you everything you need to know about the oversight involved.

• No FDA-approved injectable BPC-157 or TB-500 product exists for human use in the US.
• MK-677 was removed from the FDA bulk substances list for compounding in 2023.
• GLP-1 analog purchases without a prescription violate federal law regardless of vendor framing.
• "Something's been fishy" with orders is not a quality control system.